47 Canadian Pharmaceuticals & Biotech Stocks - Potentially Undervalued Companies - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ABBV AbbVie	US$23.45	-4.1%	7.8%	US$286.3b	US$26.59	PE47.9x	E23.3%	3.9%
CTX Crescita Therapeutics	CA$0.43	0%	-35.8%	CA$8.4m	n/a	PB0.4x	n/a	n/a
CYBN Cybin	US$0.48	4.3%	12.9%	US$266.0m	US$6.69	PB3x	E62.2%	n/a
CURA Curaleaf Holdings	CA$7.73	19.1%	120.2%	CA$5.8b	CA$11.19	PS3.1x	E58.8%	n/a
IBT IBEX Technologies	CA$1.44	0%	73.5%	CA$35.3m	n/a	PE8.9x	n/a	n/a
RX BioSyent	CA$8.69	2.1%	18.2%	CA$100.9m	CA$9.00	PE15.6x	S9.9%	2.1%
IPCI.H Intellipharmaceutics International	CA$0.08	0%	n/a	CA$2.6m	n/a	PS2.1x	n/a	n/a
VPH Valeo Pharma	CA$0.12	21.1%	-76.5%	CA$10.9m	n/a	PE-0.4x	E45.7%	n/a
AYR.A Ayr Wellness	CA$3.42	9.3%	235.3%	CA$390.6m	CA$5.96	PB0.5x	E83.3%	n/a
STPH Steep Hill	CA$0.03	20.0%	-60.0%	CA$485.4k	n/a	PB0.3x	n/a	n/a
XTRX Adastra Holdings	CA$0.20	-4.9%	-61.0%	CA$10.9m	n/a	PB0.7x	n/a	n/a
CWEB Charlotte's Web Holdings	CA$0.28	3.7%	-37.8%	CA$40.1m	n/a	PB0.6x	S1.7%	n/a
NUMI Numinus Wellness	CA$0.07	-12.5%	-56.3%	CA$24.0m	n/a	PB2.2x	E72.5%	n/a
TLRY Tilray Brands	US$2.77	14.9%	-18.8%	US$1.6b	US$3.26	PS2.2x	E86.1%	n/a
GUD Knight Therapeutics	CA$5.82	2.3%	24.4%	CA$583.8m	CA$6.75	PS1.8x	E58.4%	n/a
TILT TILT Holdings	CA$0.045	28.6%	-35.7%	CA$17.4m	n/a	PB0.2x	E45.2%	n/a
ROMJ Rubicon Organics	CA$0.37	-2.6%	-32.7%	CA$20.5m	CA$1.40	PB0.5x	E66.2%	n/a
WEED Canopy Growth	CA$14.19	19.6%	-15.5%	CA$1.2b	CA$6.15	PS2.9x	E84.6%	n/a
ONC Oncolytics Biotech	CA$1.59	6.7%	-19.7%	CA$116.1m	CA$6.63	PB4.4x	E53.6%	n/a
CL Cresco Labs	CA$2.94	10.5%	36.7%	CA$1.3b	CA$5.92	PB1.5x	E97.2%	n/a
LABS MediPharm Labs	CA$0.08	0%	0%	CA$34.3m	n/a	PB0.6x	E78.0%	n/a
JNJ Johnson & Johnson	US$20.12	1.9%	n/a	US$363.8b	US$23.25	PE21.1x	E7.0%	3.3%
CBST Cannabist Company Holdings	US$0.42	18.3%	-32.3%	US$146.3m	US$1.42	PB2.1x	E97.9%	n/a

Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies